aTyr Pharma | LIFE - Operating Expenses


aTyr Pharma reported $85.61M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Alterity Therapeutics Limited AUD 8.67M 893.38K Dec/2025
Ardelyx USD 120.12M 14.46M Dec/2025
aTyr Pharma USD 85.61M 58.67M Dec/2025
Biogen USD 1.96B 69.6M Mar/2026
Bristol-Myers Squibb USD 20.07B 11.77B Mar/2026
Cipla INR 59.27B 1.71B Mar/2026
Clal Biotechnology ILS 5.15M 9.47M Dec/2022
Compugen USD 11.29M 1.51M Dec/2025
CSL USD 5.7B 2.82B Dec/2025
Curis USD 9.02M 23.01M Dec/2025
GlaxoSmithKline GBP 5.34B 1.85B Mar/2026
Grifols EUR 1.99B 217.4M Dec/2025
Lakefront Biotherapeutics EUR 70.18M 50.08M Mar/2026
Novartis USD 9.29B 507M Mar/2026
Roche Holding CHF 21.01B 10.84B Dec/2025
United Therapeutics USD 5.9B 5.1B Mar/2026
Xoma USD 22.84M 1.67M Sep/2024